Reference database
Every dog supplement rated by research quality.
30 supplements graded on the strength of published canine evidence. No marketing claims. No affiliate bias. Just what the science actually supports.
30 supplements
| Supplement | Evidence | Primary Use | Dose (per 10 lbs) | Key Reference |
|---|---|---|---|---|
| Omega-3 (EPA/DHA) | Strong Evidence | Anti-inflammatory, skin/coat, joint support | 40-75 mg EPA+DHA | Bauer 2011, JAVMA: reduced inflammatory markers in dogs with osteoarthritis |
| Glucosamine + Chondroitin | Strong Evidence | Joint cartilage support, osteoarthritis | 20-25 mg glucosamine | McCarthy et al. 2007: significant improvement in pain and weight-bearing scores |
| Probiotics | Strong Evidence | Gut health, immune modulation, diarrhea prevention | 1-5 billion CFU | Schmitz & Suchodolski 2016: modulated gut microbiome composition in healthy dogs |
| SAMe (S-Adenosylmethionine) | Strong Evidence | Liver support, cognitive function | 18-20 mg | Center et al. 2004: improved liver function markers in dogs with hepatopathy |
| Milk Thistle (Silymarin) | Strong Evidence | Liver protection, antioxidant | 5-10 mg silymarin | Avizeh et al. 2010: hepatoprotective effect in experimentally induced liver injury in dogs |
| Green-Lipped Mussel | Moderate Evidence | Joint support, anti-inflammatory (omega-3 + GAGs) | 15-25 mg powder | Rialland et al. 2013: reduced clinical signs of osteoarthritis in a blinded trial |
| CoQ10 (Ubiquinone) | Moderate Evidence | Cellular energy, cardiac support, antioxidant | 1-2 mg | Harker-Murray et al. 2000: improved cardiac function markers in dogs with heart disease |
| Turmeric / Curcumin | Moderate Evidence | Anti-inflammatory, antioxidant | 5-10 mg curcumin | Colitti et al. 2012: reduced inflammatory cytokines in canine cell cultures; bioavailability remains a limitation |
| CBD (Cannabidiol) | Moderate Evidence | Pain management, seizure reduction, anxiety | 1-2 mg | Gamble et al. 2018: reduced pain and increased activity in dogs with osteoarthritis at 2 mg/kg BID |
| Melatonin | Moderate Evidence | Sleep regulation, anxiety, alopecia support | 0.1-0.3 mg | Arendt 2005 (human/veterinary extrapolation): regulates circadian rhythm; veterinary use supported by clinical consensus |
| L-Theanine | Moderate Evidence | Calming, anxiety reduction | 2-4 mg | Dramard et al. 2007: alpha-casozepine + L-theanine combination reduced anxiety behaviors in dogs |
| Vitamin E | Moderate Evidence | Antioxidant, skin/coat health, immune support | 1-2 IU | Hennet et al. 2007: improved oxidative stress markers in dogs fed vitamin E-enriched diets |
| Digestive Enzymes | Moderate Evidence | Nutrient absorption, pancreatic support | Per product | Wiberg et al. 1998: pancreatic enzyme supplementation improved nutrient absorption in dogs with EPI |
| NMN / NAD+ | Limited Evidence | Cellular energy, anti-aging, DNA repair | 3-8 mg | Mills et al. 2016 (mouse): restored vascular function; canine-specific studies are in early stages |
| Resveratrol | Limited Evidence | Antioxidant, sirtuin activation | 2-5 mg | Baur et al. 2006 (mouse): improved metabolic markers; no completed canine RCTs |
| Fisetin | Limited Evidence | Senolytic, anti-inflammatory | 2-5 mg | Yousefzadeh et al. 2018 (mouse): reduced senescent cell burden; canine studies pending |
| Quercetin | Limited Evidence | Antihistamine, anti-inflammatory | 5-10 mg | Karuppagounder et al. 2016: neuroprotective effects in vitro; veterinary application extrapolated from rodent data |
| Berberine | Limited Evidence | Blood sugar regulation, gut health | 5-10 mg | Zhang et al. 2012 (human/rodent): improved glucose metabolism; no published canine RCTs |
| Astaxanthin | Limited Evidence | Antioxidant, eye health, skin support | 0.1-0.5 mg | Park et al. 2013: reduced oxidative stress markers in dogs given astaxanthin-enriched diet |
| Collagen Peptides | Limited Evidence | Joint, skin, gut lining support | 10-20 mg | Bello & Oesser 2006 (human): improved joint symptoms; canine-specific data limited to open-label observations |
| Spirulina | Limited Evidence | Immune support, antioxidant, nutritional density | 5-15 mg | Satyaraj et al. 2020: spirulina supplementation showed immune-modulating effects in dogs |
| Turkey Tail Mushroom | Limited Evidence | Immune modulation, cancer adjunct support | 10-25 mg | Brown & Reetz 2012: extended survival in dogs with hemangiosarcoma in a small pilot trial |
| Boswellia | Limited Evidence | Anti-inflammatory, joint support | 5-10 mg extract | Reichling et al. 2004: combination with curcumin reduced osteoarthritis signs in dogs |
| Urolithin A | Insufficient Evidence | Mitophagy, mitochondrial health | Not established | Ryu et al. 2016 (C. elegans): extended lifespan via mitophagy; no canine data published |
| Spermidine | Insufficient Evidence | Autophagy activation, cellular renewal | Not established | Eisenberg et al. 2009 (yeast/mouse): induced autophagy and extended lifespan; no canine studies |
| Rapamycin (Dog-Specific) | Insufficient Evidence | mTOR inhibition, anti-aging | Not established | Dog Aging Project TRIAD trial: 580-dog RCT underway; preliminary results pending |
| Alpha-Lipoic Acid | Insufficient Evidence | Antioxidant, nerve support | Not established | Hill et al. 2004: ALA is potentially toxic to cats; canine safety profile requires more study at therapeutic doses |
| DHEA | Insufficient Evidence | Adrenal support, hormonal balance | Not established | Clinical use in Cushing disease (Plumb 2018); insufficient evidence for anti-aging use in healthy dogs |
| Carnosine | Insufficient Evidence | Anti-glycation, antioxidant | Not established | Boldyrev et al. 2013 (in vitro/rodent): anti-glycation properties; no published canine-specific data |
| Creatine (Dogs) | Insufficient Evidence | Muscle support, energy metabolism | Not established | Human athletic data extensive; canine studies limited to laboratory models, not companion dog protocols |
Anti-inflammatory, skin/coat, joint support
Bauer 2011, JAVMA: reduced inflammatory markers in dogs with osteoarthritis
Joint cartilage support, osteoarthritis
McCarthy et al. 2007: significant improvement in pain and weight-bearing scores
Gut health, immune modulation, diarrhea prevention
Schmitz & Suchodolski 2016: modulated gut microbiome composition in healthy dogs
Liver support, cognitive function
Center et al. 2004: improved liver function markers in dogs with hepatopathy
Liver protection, antioxidant
Avizeh et al. 2010: hepatoprotective effect in experimentally induced liver injury in dogs
Joint support, anti-inflammatory (omega-3 + GAGs)
Rialland et al. 2013: reduced clinical signs of osteoarthritis in a blinded trial
Cellular energy, cardiac support, antioxidant
Harker-Murray et al. 2000: improved cardiac function markers in dogs with heart disease
Anti-inflammatory, antioxidant
Colitti et al. 2012: reduced inflammatory cytokines in canine cell cultures; bioavailability remains a limitation
Pain management, seizure reduction, anxiety
Gamble et al. 2018: reduced pain and increased activity in dogs with osteoarthritis at 2 mg/kg BID
Sleep regulation, anxiety, alopecia support
Arendt 2005 (human/veterinary extrapolation): regulates circadian rhythm; veterinary use supported by clinical consensus
Calming, anxiety reduction
Dramard et al. 2007: alpha-casozepine + L-theanine combination reduced anxiety behaviors in dogs
Antioxidant, skin/coat health, immune support
Hennet et al. 2007: improved oxidative stress markers in dogs fed vitamin E-enriched diets
Nutrient absorption, pancreatic support
Wiberg et al. 1998: pancreatic enzyme supplementation improved nutrient absorption in dogs with EPI
Cellular energy, anti-aging, DNA repair
Mills et al. 2016 (mouse): restored vascular function; canine-specific studies are in early stages
Antioxidant, sirtuin activation
Baur et al. 2006 (mouse): improved metabolic markers; no completed canine RCTs
Senolytic, anti-inflammatory
Yousefzadeh et al. 2018 (mouse): reduced senescent cell burden; canine studies pending
Antihistamine, anti-inflammatory
Karuppagounder et al. 2016: neuroprotective effects in vitro; veterinary application extrapolated from rodent data
Blood sugar regulation, gut health
Zhang et al. 2012 (human/rodent): improved glucose metabolism; no published canine RCTs
Antioxidant, eye health, skin support
Park et al. 2013: reduced oxidative stress markers in dogs given astaxanthin-enriched diet
Joint, skin, gut lining support
Bello & Oesser 2006 (human): improved joint symptoms; canine-specific data limited to open-label observations
Immune support, antioxidant, nutritional density
Satyaraj et al. 2020: spirulina supplementation showed immune-modulating effects in dogs
Immune modulation, cancer adjunct support
Brown & Reetz 2012: extended survival in dogs with hemangiosarcoma in a small pilot trial
Anti-inflammatory, joint support
Reichling et al. 2004: combination with curcumin reduced osteoarthritis signs in dogs
Mitophagy, mitochondrial health
Ryu et al. 2016 (C. elegans): extended lifespan via mitophagy; no canine data published
Autophagy activation, cellular renewal
Eisenberg et al. 2009 (yeast/mouse): induced autophagy and extended lifespan; no canine studies
mTOR inhibition, anti-aging
Dog Aging Project TRIAD trial: 580-dog RCT underway; preliminary results pending
Antioxidant, nerve support
Hill et al. 2004: ALA is potentially toxic to cats; canine safety profile requires more study at therapeutic doses
Adrenal support, hormonal balance
Clinical use in Cushing disease (Plumb 2018); insufficient evidence for anti-aging use in healthy dogs
Anti-glycation, antioxidant
Boldyrev et al. 2013 (in vitro/rodent): anti-glycation properties; no published canine-specific data
Muscle support, energy metabolism
Human athletic data extensive; canine studies limited to laboratory models, not companion dog protocols
No supplements match your search.
Try a different name, use case, or evidence level.
How we rate evidence
Each supplement is graded based on the strength, quality, and directness of published research in dogs. We prioritize randomized controlled trials (RCTs) in companion dogs, followed by large observational studies, then data from laboratory animals or other species.
We do not accept manufacturer-funded studies as sole evidence. When multiple studies conflict, we note the inconsistency and default to the more conservative rating. Evidence levels are reviewed quarterly and adjusted as new data is published.
Dosage ranges are derived from published studies and veterinary pharmacology references. "Per 10 lbs body weight" is a simplified reference point. Always consult your veterinarian for individualized dosing, especially for dogs with health conditions or those taking medications.
Frequently asked questions
How are evidence levels assigned?
Does "limited evidence" mean a supplement is useless?
How often is this database updated?
Are the dosages listed here safe for all dogs?
Why are some well-known supplements rated as limited or insufficient?
Can I combine multiple supplements?
This database is for informational purposes only and does not constitute veterinary advice. Evidence ratings reflect published research available at the time of last review. Supplement efficacy can vary by individual dog, formulation quality, and health status. Always consult a licensed veterinarian before starting, stopping, or changing any supplement regimen.